UF study finds FDA strategy cuts fetal exposure to harmful immunosuppressive drug, but risks remain
University of Florida researchers determined an FDA-approved program deters pregnant women from starting a potentially harmful immunosuppressive drug. But for women taking the drug, the program was not effective at reducing conception.